The rate limiting step in 5-fluorouracil catabolism is catalyzed by the enzyme dihydropyrimidine dehydrogenase. Since degradation of 5-fluorouracil decreases its efficacy in chemotherapy, the inhibition of its catabolism is a promising tool. We investigated the formation of micronuclei in vitro in mouse L5178Y cells. 5-fluorouracil induced an increase in micronucleus frequency, which could significantly be enhanced by the concurrent application of 2,6-dihydroxypyridine, an inhibitor of dihydropyrimidine dehydrogenase. The 5-fluorouracil concentration necessary to reach maximal genotoxic effects could be reduced to half in the presence of inhibitor. 2,6-Dihydroxypyridine alone and the naturally occuring enzyme substrate uracil did not induce micronucleus formation. Combined application of the chemotherapeutic agent 5-fluorouracil and an inhibitor of its could reduce side-effects by lowering the effective dose of the active drug. With this study we provide further support for the usefulness of this concept. " 
between 60% and 90% of the applied 5-FU. Therefore, inhibitors of this enzyme may be useful as chemotherapeutic agents by enhancing the antitumor activity of 5-FU. Most of the compounds that are used to inhibit enzymatic uracil reduction, are reduced by DPD. In contrast to these compounds the radiosensitizing drug 5-jodouracil acts as suicide substrate by covalent modification of an active site cystein residue (4). 5-Ethynyluracil is an other mechanism-based irreversible inhibitor of DPD (5) . It has been shown in rat and mouse models that 5-ethynyluracil potentiales the antitumor activity and the toxicity of 5-FU. The antitumor activity increases to a greater degree and thereby the therapeutic index of 5-FU increases 2-to 4-fold. In the extended Iist of ligands of DPD (6) one of the most effective inhibitors is DHP. It has strong inhibitory activity without acting as a substrate for the enzyme (7) . DHP has been used in defining the kinetic mechanism of pig liver DPD (8) . The enzyme processes the reactants (NADPH and e.g. uracil or 5-FU) at separate, nonoverlapping catalytic sites that are linked by an intermolecular electron transport chain. The pig liver enzyme is an excellent model for human DPD showing similar physical, kinetic and immunological properlies (9).
We investigated 5-FU-induced micronucleus-formation in mause L5178Y cells. This cell line has been shown to be suitable for analysis of micronucleus induction (10, 11 ) . The main question was whether the genotoxicity of 5-FU could be enhanced in vitro by inhibiting 5-FU catabolism.
Material and Methods
Material: Bisbenzimide 33258 and 5-FU were obtained from Sigma, DHP was from Aldrich. F-DHU was generously supplied by Hoffmann-La Roche AG, Basel, Switzerland.
Cell culture: Mouse L5178Y cells, clone 3.7.2c, were cultured in suspension in RPMI-1640 supplemented with antibiotics, 0.25 mg/ml L-glutamine, 107 J.tg/ml sodium pyruvate and 10% heat inactivated horse serum (Sigma Chemie GmbH, Deisenhofen, Germany). Cell cultures were grown in a humidified atmosphere with 5% C02 in air at 37°C.
In vitro micronucleus assay: Exponentially growing mause L5178Y cells which have a doubling time of 10 hours were treated for 4 hours. The vehicle control was 1% DMSO. After removing the chemieals by centrifugation and medium replacement, the cells were incubated for 15 hours for dose-response experiments or for 0 to 25 hours for time course experiments (expression time). The cells were then brought onto glass slides by cytospin-centrifugation and were fixed with methanol (-20°C, 1 hour). For the staining of nuclei and micronuclei, the slides were washed with destilled water, incubated with bisbenzimide 33258 (5 1-'g/ml, 3 min.), washed three times with destilled water and mounted for microscopy. Using a magnification of 1250x the numbers of nuclei and micronuclei were scored. Each data point represents the mean of three slides with 2000 nuclei evaluated per slide. Allexperiments were repeated with consistent results.
Preparation of cell extracts: Cells in suspension were collected by centrifigation for 30 min at 10,000 g. The cells were broken by hypotonic treatment in 10 ml ofhomogenation buffer. In the control experiment the homogenation buffer contained 35 mM potassium phosphate, pH 7.3, I mM DTE ( = buffer A). In the other experiments cells were homogenized in a) buffer A plus 9. 75 J.tM 5-FU, b) buffer A plus 0.2 #-'M DHP or c) buffer A plus 9. 75 #-'M 5-FU and 0.2 #-'M DHP. After centrifugation at 20,000 g for 30 min the supematant fluid was concentrated to a volume of 1 ml by Ultrafiltration using centricon 10 devices (Amicon). All steps were performed at 4 oc. The concentrated fluids (cytosol) had protein contents of 10.11 mg/ml and were used for DPD assays as described (12) . Protein was determined according to Schaffner and Weisman (13) .
Micronucleus formation after treatment with 5-FU was investigated using mouse L5178Y cells. The micronucleus frequency increased in a dose dependent roanner ( Fig. la) and decreased after reaching a maximum at 19.5 #'M. The time course of micronucleus forroation after application of 19.5 #'M 5-FU (Fig. lb) showed that the micronucleus frequency was optimal after an expression time of 15 hours. There was no visible toxicity at this time point, whereas some toxicity resulting in damaged nuclei could be seen at 25 hours. Cell growth was also impaired at 25 hours. This was reflected in a reduced cell nurober in the treated culture at the time of cell fixation to 33% compared to an untreated control culture. At 15 hours, cell nurober was 86% of the control. Therefore, an expressiontime of 15 hours was considered appropriate for further investigation of 5-FU-induced roicronuclei.
Uracil, a naturally occuring substrate of DPD, did not induce roicronuclei if applied under comparable conditions (fable 1). The pyriroidine-product (F-DHU) of the reaction catalysed by DPD was also investigated and was found not to induce micronuclei under comparable conditions (Table 1) .
A putative enhancing effect of the inhibitor DHP on the roicronucleus inducing capacity of 5-FU was investigated. DHP fits much better into the uracil binding site of DPD than 5-FU, as indicated by kinetic studies on the pig liver enzyroe (8) . The true Kj-value is 0.007 #'M for competition of DHP with the natural substrate uracil to bind at the pyriroidine binding site. In pig liver DPD the Kro-value for 5-FU is 5.5 #'M. Since the Kro(5-FU)1Ki(DHP) ratio is approximately 800, a much smaller concentration of DHP than 5-FU should inhibit the metabolising step sufficiently. However, interactions with components of the cell culture medium are possible and the most effective concentration had to be determined experimentally. First, it was examined whether DHP itself induced micronuclei (Table 1) when measuring cell growth and trypan blue uptake (data not shown). As the result of an experiment, in which the concentration of 5-FU was kept at 9. 75 I'M and the concentration of DHP was varied (Fig. 2a) , 0.195 J.tM DHP was chosen as being appropriate for further investigations.
The combination of DHP and 5-FU was further examined (Fig. 2b) . While DHP alone again did not induce micronuclei, 5-FU did. The combination of both yielded the highest micronucleus frequency. This increase of micronucleus frequency was reproducible in 3 independent experiments (data not shown). As a final experiment, a dose response for micronucleus induction by 5-FU in the presence of DHP was performed (Fig. 3 ) and compared to that without DHP These results are promising in view of a possible use of such a combination in chemotherapy. It might be possible to influence the other factors which Iead to the additional toxicity in order to optimize the therapeutic index of 5-FU. With our study we could provide further support for the usefulness of the concept that the chemotherapeutic agent 5-FU may be combined with a compound able to inhibit one of the three pyrimidine catabolizing enzymes.
